Table 8.

Percentage of patients demonstrating antibody response to hu14.18-IL2 following each course

Course*nPercentage of patients showing anti-immunocytokine antibody
Anti-idiotype
Anti-Fc
++++++
128393625501832
220302050501535
3154075347747
4112796436955
  • NOTE: −, <29% inhibition for both assays; +, 29% to 50% inhibition for anti-idiotype and 29% to 40% inhibition for anti-Fc-IL2; ++, >50% inhibition for anti-idiotype and > 40% inhibition for anti-Fc-IL2.

  • * Serum specimen obtained after each designated course.